Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2
- PMID: 2987382
Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2
Abstract
Primary cultures of human hepatocytes and the human hepatocellular cell line Hep G2 are shown to produce fast-acting inhibitors of tissue-type plasminogen activator (tPA) and urokinase. The tPA inhibitory activities in conditioned medium of these liver cell types are very similar to those present in human endothelial cell conditioned medium. They are stable at pH 2.5, have similar dissociation constants with tPA (1.5 to 5 pmol/L), and are similar in thermostability. Addition of tPA to conditioned medium of Hep G2 and endothelial cells that has been depleted of tPA and urokinase reveals a 100 kilodalton tPA-inhibitor complex. The fast-acting tPA inhibitory activity in human plasma has comparable properties, and may originate from the liver or the vascular endothelium or both. After sodium dodecyl sulfate-polyacrylamide gel electrophoresis of conditioned medium from hepatocytes, Hep G2, and endothelial cells, additional fibrinolytic inhibition at 52 kilodaltons was visualized. This was not found with human plasma.
Similar articles
-
Human hepatoma cell line plasminogen activator.J Lab Clin Med. 1983 Oct;102(4):500-8. J Lab Clin Med. 1983. PMID: 6311924
-
Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2.Thromb Haemost. 1988 Dec 22;60(3):491-4. Thromb Haemost. 1988. PMID: 3149048
-
Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells.Thromb Haemost. 1985 Apr 22;53(2):165-9. Thromb Haemost. 1985. PMID: 3927503
-
Fibrinolytic system of cultured endothelial cells: regulation by plasminogen activator inhibitor.J Cell Biochem. 1986;32(4):273-80. doi: 10.1002/jcb.240320404. J Cell Biochem. 1986. PMID: 3100541 Review.
-
Hormonal regulation of membrane phenotype in hepatoma cells.Ann N Y Acad Sci. 1980;349:210-20. doi: 10.1111/j.1749-6632.1980.tb29527.x. Ann N Y Acad Sci. 1980. PMID: 6261629 Review. No abstract available.
Cited by
-
Plasma t-PA and PAl-1 antigen concentrations in non-insulin dependent diabetic patients: effects of treatment modality on fibrinolysis.Korean J Intern Med. 1992 Jul;7(2):81-6. doi: 10.3904/kjim.1992.7.2.81. Korean J Intern Med. 1992. PMID: 1306076 Free PMC article.
-
Fibrinolytic changes in a patient with toxic shock syndrome; release of active u-PA.Intensive Care Med. 1998 Mar;24(3):258-61. doi: 10.1007/s001340050561. Intensive Care Med. 1998. PMID: 9565810
-
Regulation of fibrin deposition by malignant mesothelioma.Am J Pathol. 1995 Nov;147(5):1318-29. Am J Pathol. 1995. PMID: 7485395 Free PMC article.
-
Splenectomy Improves Hemostatic and Liver Functions in Hepatosplenic Schistosomiasis Mansoni.PLoS One. 2015 Aug 12;10(8):e0135370. doi: 10.1371/journal.pone.0135370. eCollection 2015. PLoS One. 2015. PMID: 26267788 Free PMC article. Clinical Trial.
-
Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage.J Clin Invest. 1989 Jul;84(1):181-93. doi: 10.1172/JCI114139. J Clin Invest. 1989. PMID: 2738151 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources